Eton Pharmaceuticals, Inc. (ETON) has 18 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $13.0M. Most recent filing: Aug. 31, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 31, 2026 filed Aug. 28, 2026 | MAIER PAUL V Director | — | +12,500 | — | No | |
|
|
||||||
| Aug. 28, 2026 | MAIER PAUL V Director | $2,764,572 | 150,000 | — | No | |
|
|
||||||
| Aug. 24, 2026 | Krempa David Chief Business Officer | $1,444,000 | 75,000 | 0% | No | |
|
|
||||||
| Aug. 20, 2026 filed Aug. 19, 2026 | BRYNJELSEN SEAN President & CEO | −$6,087,773 | 100,000 | −9% | No | |
|
|
||||||
| Aug. 4, 2026 filed July 31, 2026 | CASAMENTO CHARLES J Director | $0 | 10,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 18 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free